Testing HR+ / HER2-patients with advanced or metastatic breast cancer for identification of tissue mutations in the PIK3CA gene: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO)

被引：0
|
作者：
Boutis, A. [1 ]
Nikolaou, M. [1 ]
Ardavanis, A. [1 ]
Tolis, C. [1 ]
Loga, K. [1 ]
Korantzis, I. [1 ]
Koumarianou, A. [1 ]
Christopoulou, A. N. [1 ]
Papatsimpas, G. [1 ]
Bokas, A. [1 ]
Pliarchopoulou, K. [1 ]
Kampletsas, E. [1 ]
Kesisis, G. [1 ]
Biziota, E. [1 ]
Psianou, K. [1 ]
Karageorgopoulou, S. [1 ]
Sogka, E. A. [1 ]
Tsoukalas, N. G. [1 ]
Chatzifoti, N. [1 ]
Saridaki-Zoras, Z. [1 ]
机构：
[1] Hellenic Soc Med Oncol, HeSMO, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439P
引用
收藏
页码：S366 / S366
页数：1
相关论文
共 50 条
  • [1] Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue
    Vollbrecht, Claudia
    Hoffmann, Inga
    Lehmann, Annika
    Merkelbach-Bruse, Sabine
    Fassunke, Jana
    Wagener-Ryczek, Svenja
    Ball, Markus
    Dimitrova, Lora
    Hartmann, Arndt
    Stohr, Robert
    Erber, Ramona
    Weichert, Wilko
    Pfarr, Nicole
    Bohlmann, Lisa
    Jung, Andreas
    Dietmaier, Wolfgang
    Dietel, Manfred
    Horst, David
    Hummel, Michael
    VIRCHOWS ARCHIV, 2023, 482 (04) : 697 - 706
  • [2] Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue
    Claudia Vollbrecht
    Inga Hoffmann
    Annika Lehmann
    Sabine Merkelbach-Bruse
    Jana Fassunke
    Svenja Wagener-Ryczek
    Markus Ball
    Lora Dimitrova
    Arndt Hartmann
    Robert Stöhr
    Ramona Erber
    Wilko Weichert
    Nicole Pfarr
    Lisa Bohlmann
    Andreas Jung
    Wolfgang Dietmaier
    Manfred Dietel
    David Horst
    Michael Hummel
    Virchows Archiv, 2023, 482 : 697 - 706
  • [3] PIK3CA Mutation Assessment in HR+/HER2-Metastatic Breast Cancer: Overview for Oncology Clinical Practice
    Criscitiello, Carmen
    Marra, Antonio
    Curigliano, Giuseppe
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (01): : 42 - 54
  • [4] A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2-Metastatic Breast Cancer
    Anderson, Elizabeth J.
    Mollon, Lea E.
    Dean, Joni L.
    Warholak, Terri L.
    Aizer, Ayal
    Platt, Emma A.
    Tang, Derek H.
    Davis, Lisa E.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2020, 2020
  • [5] A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HR+/HER2-metastatic breast cancer
    Mollon, Lea
    Aguilar, Alejandra
    Anderson, Elizabeth
    Dean, Joni
    Davis, Lisa
    Warholak, Terri
    Aizer, Ayal A.
    Platt, Emma
    Bardiya, Aditya
    Tang, Derek
    CANCER RESEARCH, 2018, 78 (13)
  • [6] A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer
    Mollon, Lea E.
    Anderson, Elizabeth J.
    Dean, Joni L.
    Warholak, Terri L.
    Aizer, Ayal
    Platt, Emma A.
    Tang, Derek H.
    Davis, Lisa E.
    CLINICAL BREAST CANCER, 2020, 20 (03) : E232 - E243
  • [7] PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2-breast cancer
    Teran, Eduardo
    Lozano, Rebeca
    Rodriguez, Cesar A.
    Abad, Mar
    Figuero, Luis
    Munoz, Jose Antonio
    Cigarral, Belen
    Rodrigues, Aline
    Sancho, Magdalena
    Gomez, M. Asuncion
    Morchon, Daniel
    Montero, Juan Carlos
    Sayagues, Jose Maria
    Ludena, M. Dolores
    Fonseca, Emilio
    CANCER MEDICINE, 2024, 13 (17):
  • [8] A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2-breast cancer patients
    Dandachi, N.
    Graf, R.
    Pancheri, L.
    Dobric, N.
    Klocker, E. V.
    Suppan, C.
    Jost, P. J.
    Heitzer, E.
    Balic, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1162 - S1163
  • [9] A systematic literature review of the clinical prognosis of HR+/HER2-advanced or metastatic breast cancer with and without PIK3CA mutation.
    Anderson, Elizabeth J.
    Mollon, Lea
    Dean, Joni L.
    Aguilar, Alejandra
    Davis, Lisa E.
    Warholak, Terri L.
    Aizer, Ayal Aaron
    Platt, Emma
    Bardia, Aditya
    Tang, Derek
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] PIK3CA mutational status in tissue & plasma as a prognostic tool in HR+/HER2-breast cancer (BC)
    Brage, Eduardo Teran
    Mejorada, Rebeca Lozano
    Francoso, Aline Rodrigues
    Leon, Jose Antonio Munoz
    Gutierrez, Alvaro Lopez
    Figuero-Perez, Luis
    Araujo, Daniel Morchon
    Martinez, Maria Garijo
    Ruiz, Jonnathan Roldan
    Hernandez, Maria Mar Abad
    de Salas, Magdalena Sancho
    Sanchez, Emilio Fonseca
    Sanchez, Cesar Augusto Rodriguez
    CANCER RESEARCH, 2024, 84 (09)
12345